Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor.
Uleri A, Contieri R, Moretto S, Cieri M, Paciotti M, Hurle R, Fasulo V, Arena P, Massimo L, Avolio P, Mallia V, Buffi N, Colombo P, Lughezzani G. Uleri A, et al. Among authors: cieri m. Eur Urol Open Sci. 2024 Sep 17;69:71-72. doi: 10.1016/j.euros.2024.08.016. eCollection 2024 Nov. Eur Urol Open Sci. 2024. PMID: 39329072 Free PMC article. No abstract available.
A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer.
Piccolini A, Avolio PP, Saitta C, Beatrici E, Moretto S, Aljoulani M, Dagnino F, Maffei D, Frego N, Fasulo V, Paciotti M, Hurle R, Saita A, Lazzeri M, Casale P, Colombo P, Cieri M, Buffi NM, Lughezzani G. Piccolini A, et al. Among authors: cieri m. Eur Urol Open Sci. 2024 Sep 12;69:7-12. doi: 10.1016/j.euros.2024.08.013. eCollection 2024 Nov. Eur Urol Open Sci. 2024. PMID: 39314912 Free PMC article.
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.
Contieri R, Lughezzani G, Buffi NM, Taverna G, Giacobbe A, Micheli E, Barra S, Colombo P, Vanni E, Guazzoni G, Lazzeri M, Hurle R; HuNIRe Study Group. Contieri R, et al. Front Oncol. 2022 May 18;12:879399. doi: 10.3389/fonc.2022.879399. eCollection 2022. Front Oncol. 2022. PMID: 35664755 Free PMC article.
Non-muscle invasive bladder cancer biomarkers beyond morphology.
De Carlo C, Valeri M, Corbitt DN, Cieri M, Colombo P. De Carlo C, et al. Among authors: cieri m. Front Oncol. 2022 Aug 3;12:947446. doi: 10.3389/fonc.2022.947446. eCollection 2022. Front Oncol. 2022. PMID: 35992775 Free PMC article. Review.
Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients.
Valeri M, Contieri R, Fasulo V, Iuzzolino M, Cieri M, Elefante GM, De Carlo C, Bressan A, Saitta C, Gobbo A, Avolio PP, Dacrema V, Lazzeri M, Taverna G, Terracciano LM, Hurle R, Colombo P. Valeri M, et al. Among authors: cieri m. Cancers (Basel). 2023 Feb 1;15(3):934. doi: 10.3390/cancers15030934. Cancers (Basel). 2023. PMID: 36765894 Free PMC article.
52 results